DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/gs6kvj/osteoarthritis) has announced the addition of the "Osteoarthritis - Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic development for Osteoarthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteoarthritis and special features on late-stage and discontinued projects.
The report features investigatory drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by our team.
- The report provides a snapshot of the global therapeutic landscape of Osteoarthritis
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Osteoarthritis and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Osteoarthritis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- A. Menarini Industrie Farmaceutiche Riunite Srl
- AbbVie Inc.
- Abiogen Pharma S.p.A.
- Ablynx NV
- AcurePharma AB
- Addex Therapeutics
- Allinky Biopharma
- Ampio Pharmaceuticals, Inc.
- Amura Holdings Ltd.
- Asahi Kasei Pharma Corp.
- Asklepios BioPharmaceutical, Inc.
- Astellas Pharma Inc.
- Aurigene Discovery Technologies Limited
- Biopharm GmbH
- Bone Medical Limited
- Calzada Limited
- Can-Fite BioPharma Ltd.
- Cellceutix Corporation
- Cellular Biomedicine Group, Inc.
- Chong Kun Dang Pharmaceutical Corp.
- Chugai Pharmaceutical Co., Ltd.
- CrystalGenomics, Inc.
- Galapagos NV
- Genequine Biotherapeutics GmbH
- Janssen Biotech, Inc.
- Jenrin Discovery, Inc.
- Laila Pharmaceuticals Pvt. Ltd.
- MediPost Co., Ltd.
- Medivir AB
- Merck KGaA
For more information visit http://www.researchandmarkets.com/research/gs6kvj/osteoarthritis